GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism.
about
Oxidative stress and protein oxidation in the brain of water drinking and alcohol drinking rats administered the HIV envelope protein, gp120NAAG peptidase inhibition in the periaqueductal gray and rostral ventromedial medulla reduces flinching in the formalin model of inflammationAdvances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide familyGroup II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia.Anisotropically organized three-dimensional culture platform for reconstruction of a hippocampal neural network.Oral administration of the NAALADase inhibitor GPI-5693 attenuates cocaine-induced reinstatement of drug-seeking behavior in rats.Altered expression and function of small-conductance (SK) Ca(2+)-activated K+ channels in pilocarpine-treated epileptic ratsHigh-field proton magnetic resonance spectroscopy reveals metabolic effects of normal brain aging.Glutamate carboxypeptidase II gene knockout attenuates oxidative stress and cortical apoptosis after traumatic brain injury.Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophreniaGroup II metabotropic glutamate receptors inhibit glutamate release at thalamocortical synapses in the developing somatosensory cortex.Differential changes in mGlu2 and mGlu3 gene expression following pilocarpine-induced status epilepticus: a comparative real-time PCR analysisImpaired expression and function of group II metabotropic glutamate receptors in pilocarpine-treated chronically epileptic rats.Localization of NAAG-related gene expression deficits to the anterior hippocampus in schizophreniaLong-Term Intake of Uncaria rhynchophylla Reduces S100B and RAGE Protein Levels in Kainic Acid-Induced Epileptic Seizures RatsNAAG, NMDA receptor and psychosisBlockade of N-acetylaspartylglutamate peptidases: a novel protective strategy for brain injuries and neurological disorders.The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological diseaseA role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ43 and 2-PMPA.NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer's, and Ethanol Intoxication.Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model.NAAG peptidase inhibitor improves motor function and reduces cognitive dysfunction in a model of TBI with secondary hypoxia.Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity/transmission in the amygdala in a mouse inflammatory pain model.NAAG peptidase inhibitor reduces cellular damage in a model of TBI with secondary hypoxiaIntracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain.Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBINAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR.NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat.Effect of N-acetylaspartylglutamate (NAAG) on non-quantal and spontaneous quantal release of acetylcholine at the neuromuscular synapse of rat.Endogenous N-acetylaspartylglutamate reduced NMDA receptor-dependent current neurotransmission in the CA1 area of the hippocampus.Blocking glutamate carboxypeptidase II inhibits glutamate excitotoxicity and regulates immune responses in experimental autoimmune encephalomyelitis.Integrator or Coincidence Detector: A Novel Measure Based on the Discrete Reverse Correlation to Determine a Neuron's Operational Mode.
P2860
Q28565475-2198B6EC-B2B2-4B00-A9EF-860DF4A77326Q30459203-9F76D0FA-C471-4945-B96C-C96DA1A91070Q30465259-E4B2CC62-9822-4957-ABA1-B3522FA0F3CCQ30466262-B129C8D4-C3C7-4708-8045-44D358D91897Q30837882-3031FA4E-2E83-472E-A443-22150B769D21Q33641563-D15C06CB-828A-4F4D-B24A-AEB76CF77ED1Q34047643-81E62422-01C4-482F-BE86-042A31B14537Q34240827-B64EFDBC-2BDB-433E-A7A7-BB60F68AC45FQ35993112-38C8594B-5153-4E84-89B3-E1516B4B4A1AQ36052391-886C76B6-7C39-4693-B188-392E5FA5B342Q36948914-CAA2F246-27E4-4DED-9125-B5A2B39FF409Q37102095-461DC5E1-DEA4-4899-B8C2-38B23942217FQ37102115-2E387156-79D4-4E03-AD55-909C1A217FC5Q37199826-DCA370E6-1403-4C97-B65A-E653F00A94A5Q37689866-9EB8A28A-8145-4FA7-9AD0-7742F91004C4Q37981289-F1373EB9-B152-447E-A034-EE2BD3056C87Q38185090-62833860-89D5-4246-820A-D5C5F2DDB11AQ38831232-8666112F-140C-406D-A75E-740D9142FA63Q38887993-F9C14310-CC9C-4184-90C2-1454B0B54FEEQ38912835-45AAE0FC-57AD-46C8-9DAB-E276E05643D7Q40539364-0AF603DE-31DC-47BC-B782-B715859014CCQ41512816-31618973-2333-4280-84B4-E43D4E68FB84Q42065018-43DB842D-CD97-4366-9D3C-E8D5E300AAA6Q42285300-6E1D5978-3031-4C2B-8AAA-85850A416E84Q42397202-869D33A7-1ED0-46D9-B018-305F53AF495BQ42742435-AFE839FF-7083-404C-B807-11BB6200925BQ44893918-C6B53437-4F7D-4DE2-BC63-671A910340F0Q46142561-961E530E-19B1-4910-A1FF-380EEE7A59FCQ46543755-A01B3ED2-1947-4C0E-A543-24DBB73AF129Q48302212-515744FA-B20C-42EB-9B99-69E7EC0A4724Q48611622-E3488A82-0EDE-4507-93C4-7678FD16336EQ51186687-A415249C-DAEE-4E6B-8082-38782D7F10A2
P2860
GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
GCP II (NAALADase) inhibition ...... on by a presynaptic mechanism.
@ast
GCP II (NAALADase) inhibition ...... on by a presynaptic mechanism.
@en
type
label
GCP II (NAALADase) inhibition ...... on by a presynaptic mechanism.
@ast
GCP II (NAALADase) inhibition ...... on by a presynaptic mechanism.
@en
prefLabel
GCP II (NAALADase) inhibition ...... on by a presynaptic mechanism.
@ast
GCP II (NAALADase) inhibition ...... on by a presynaptic mechanism.
@en
P2093
P2860
P356
P1476
GCP II (NAALADase) inhibition ...... on by a presynaptic mechanism.
@en
P2093
Barbara S Slusher
Emilio R Garrido Sanabria
Krystyna M Wozniak
P2860
P304
P356
10.1152/JN.00465.2003
P407
P50
P577
2003-08-13T00:00:00Z